Eric Shrier

511 total citations
23 papers, 390 citations indexed

About

Eric Shrier is a scholar working on Ophthalmology, Molecular Biology and Neurology. According to data from OpenAlex, Eric Shrier has authored 23 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Ophthalmology, 6 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Eric Shrier's work include Retinal Diseases and Treatments (10 papers), Glaucoma and retinal disorders (4 papers) and Retinal Development and Disorders (4 papers). Eric Shrier is often cited by papers focused on Retinal Diseases and Treatments (10 papers), Glaucoma and retinal disorders (4 papers) and Retinal Development and Disorders (4 papers). Eric Shrier collaborates with scholars based in United States and Ukraine. Eric Shrier's co-authors include Iván Bódis-Wollner, Sofya Glazman, Yin Ding, Ivan Selesnick, Y. Ding, Wendy L. Hill, Shahnaz Miri, Cathleen P. Buchanan, Piotr B. Kozlowski and Lester F. Lau and has published in prestigious journals such as Journal of Biological Chemistry, Investigative Ophthalmology & Visual Science and Pharmacology Biochemistry and Behavior.

In The Last Decade

Eric Shrier

22 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Shrier United States 10 217 188 148 91 43 23 390
Milton N. Moraes-Filho Brazil 12 258 1.2× 356 1.9× 38 0.3× 81 0.9× 29 0.7× 17 519
Anna Maria De Negri Italy 10 205 0.9× 358 1.9× 42 0.3× 35 0.4× 13 0.3× 22 476
C M Yancey United States 6 172 0.8× 117 0.6× 44 0.3× 136 1.5× 32 0.7× 7 362
Etienne M. Schönbach United States 14 395 1.8× 311 1.7× 26 0.2× 194 2.1× 17 0.4× 30 505
Milton Moraes Brazil 8 256 1.2× 391 2.1× 36 0.2× 84 0.9× 30 0.7× 11 534
Shinki Chin Japan 13 207 1.0× 80 0.4× 53 0.4× 75 0.8× 33 0.8× 35 415
Élodie Reboussin France 12 170 0.8× 134 0.7× 15 0.1× 89 1.0× 97 2.3× 17 485
Ramin Sarrafizadeh United States 8 328 1.5× 37 0.2× 73 0.5× 304 3.3× 6 0.1× 13 433
Branka Stirn Kranjc Slovenia 8 33 0.2× 89 0.5× 34 0.2× 26 0.3× 26 0.6× 21 220
E. Alexandridis Germany 10 218 1.0× 91 0.5× 18 0.1× 106 1.2× 16 0.4× 61 345

Countries citing papers authored by Eric Shrier

Since Specialization
Citations

This map shows the geographic impact of Eric Shrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Shrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Shrier more than expected).

Fields of papers citing papers by Eric Shrier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Shrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Shrier. The network helps show where Eric Shrier may publish in the future.

Co-authorship network of co-authors of Eric Shrier

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Shrier. A scholar is included among the top collaborators of Eric Shrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Shrier. Eric Shrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yazdanyar, Amirfarbod, Charles L. Cai, Jacob V. Aranda, Eric Shrier, & Kay D. Beharry. (2023). Comparison of Bevacizumab and Aflibercept for Suppression of Angiogenesis in Human Retinal Microvascular Endothelial Cells. Pharmaceuticals. 16(7). 939–939. 2 indexed citations
2.
Hand, Ivan & Eric Shrier. (2018). Lack of Association of Intraventricular Hemorrhage with Retinopathy of Prematurity. Journal of Pediatric Neurology. 17(6). 219–222. 2 indexed citations
3.
4.
Glazman, Sofya, et al.. (2017). Non-Exudative Age-Related Macular Degeneration Foveal Avascular Zone Area, Foveal Vessel Density, and Ganglion Cell Complex Thickness. Investigative Ophthalmology & Visual Science. 58(8). 36–36. 3 indexed citations
5.
Shrier, Eric, et al.. (2017). Pediatric Bilateral Blue Laser Pointer-Induced Maculopathy. Case Reports in Ophthalmology. 8(1). 152–156. 8 indexed citations
6.
Shrier, Eric, et al.. (2017). Gemcitabine-Induced Retinopathy. Retina. 37(11). e130–e131. 5 indexed citations
7.
Tan, Jeffrey J., et al.. (2017). Ocular Adverse Effects of Intravitreal Bevacizumab Are Potentiated by Intermittent Hypoxia in a Rat Model of Oxygen-Induced Retinopathy. Journal of Ophthalmology. 2017. 1–14. 12 indexed citations
8.
Miri, Shahnaz, Eric Shrier, Sofya Glazman, et al.. (2015). The avascular zone and neuronal remodeling of the fovea in Parkinson disease. Annals of Clinical and Translational Neurology. 2(2). 196–201. 34 indexed citations
9.
Ding, Yin, Sofya Glazman, Eric Shrier, et al.. (2014). Application of an OCT data-based mathematical model of the foveal pit in Parkinson disease. Journal of Neural Transmission. 121(11). 1367–1376. 21 indexed citations
10.
Shrier, Eric. (2014). Cotton-Tip Applicator Lid Retraction Technique for Controlled Intravitreal Injection. Retina. 34(6). 1244–1246. 11 indexed citations
11.
12.
Shrier, Eric, et al.. (2013). FIBERGLASS INTRAOCULAR FOREIGN BODY WITH NO INITIAL OCULAR SYMPTOMS. Retinal Cases & Brief Reports. 8(1). 10–12. 4 indexed citations
13.
Shrier, Eric, et al.. (2013). Degradome Products of the Matricellular Protein CCN1 as Modulators of Pathological Angiogenesis in the Retina. Journal of Biological Chemistry. 288(32). 23075–23089. 29 indexed citations
14.
Shrier, Eric, et al.. (2013). Correlation of Inner Retinal Thickness Evaluated by Spectral-Domain Optical Coherence Tomography and Contrast Sensitivity in Parkinson disease. Journal of Neuro-Ophthalmology. 33(2). 137–142. 68 indexed citations
15.
Ding, Y., et al.. (2012). Remodeling of the fovea in Parkinson disease. Journal of Neural Transmission. 120(5). 745–753. 64 indexed citations
16.
Shrier, Eric, et al.. (2012). Interocular Asymmetry of Foveal Thickness in Parkinson Disease. Journal of Ophthalmology. 2012. 1–6. 64 indexed citations
17.
Lazzaro, Douglas R., et al.. (2011). Association of Intraventricular Hemorrhage with Retinopathy of Prematurity. Investigative Ophthalmology & Visual Science. 52(14). 3141–3141. 1 indexed citations
18.
Shrier, Eric. (2004). Vitreous Opacities and Retinal Vascular Abnormalities in Gaucher Disease. Archives of Ophthalmology. 122(9). 1395–1395. 26 indexed citations
19.
Hill, Wendy L., et al.. (1994). Tonic immobility and high‐intensity calls in a precocial chick as a function of age, diet, and time of day. Developmental Psychobiology. 27(6). 331–342. 6 indexed citations
20.
Buchanan, Cathleen P., Eric Shrier, & Wendy L. Hill. (1994). Time-dependent effects of PCPA on social aggression in chicks. Pharmacology Biochemistry and Behavior. 49(3). 483–488. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Milton N. Moraes-Filho Breakdown of academic impact, for papers by Anna Maria De Negri Breakdown of academic impact, for papers by C M Yancey Breakdown of academic impact, for papers by Etienne M. Schönbach Breakdown of academic impact, for papers by Milton Moraes Breakdown of academic impact, for papers by Shinki Chin Breakdown of academic impact, for papers by Élodie Reboussin Breakdown of academic impact, for papers by Ramin Sarrafizadeh Breakdown of academic impact, for papers by Branka Stirn Kranjc Breakdown of academic impact, for papers by E. Alexandridis
Rankless by CCL
2026